MCP-1/CCR2 signaling mediates CD16+ monocyte-driven thrombus fibrosis in Chronic Thromboembolic Pulmonary Hypertension - Amsterdam 2025

Chronic thromboembolic pulmonary hypertension: new pathogenic mechanisms and treatment approaches

Chair(s): Robin Condliffe, Luai Khalaili

Session type: Poster session

MCP-1/CCR2 signaling mediates CD16+ monocyte-driven thrombus fibrosis in Chronic Thromboembolic Pulmonary Hypertension

Maohe Chen

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Balloon pulmonary angioplasty combined with rehabilitation for chronic thromboembolic pulmonary hypertension patient post pulmonary endarterectomy without residual pulmonary hypertension

Zhihui Fu

Abstract

Survey of treatment approaches in the TEAM registry

Joanna Pepke-zaba

Poster

Abstract

Artificial intelligence in detecting and quantifying thrombotic burden compared to manual analysis using CTPA

Lojain Abdulaal

Poster

Abstract

Surgical outcomes in pulmonary hypertension a single centre study

William Kerrigan

Poster

Abstract

Dysregulation of Immune Cells and Platelet-Monocyte Aggregates in Chronic Thromboembolic Pulmonary Hypertension

Lu Sun

Poster

Abstract

The effect of high altitude (2500 m) on right heart function during exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. A randomized controlled crossover trial.

Julian Müller

Poster

Abstract

Tolerability and pharmacokinetics of inhaled liposomal iloprost in healthy adults show its potential of treating CTEPH

Pei Kan

Poster

Abstract

Safety and efficacy of percutaneous pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension in a low-population country

Frédéric Lador

Poster

Abstract

MCP-1/CCR2 signaling mediates CD16+ monocyte-driven thrombus fibrosis in Chronic Thromboembolic Pulmonary Hypertension

Maohe Chen

Poster

Abstract

Assessment of fractional exhaled nitric oxide following balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension

Jian Guo

Poster

Abstract

Pulmonary hypertension targeted therapies in patients with operable chronic thromboembolic pulmonary hypertension: USA referral center analysis

Barbara Teixeira

Poster

Abstract

Bleeding under anticoagulant therapy in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: incidence and prognostic impact, data from the HEMA-HTP study.

Laurent Bertoletti

Poster

Abstract

Anticoagulant treatment and survival in patients with pulmonary arterial hypertension: data from the French PH registry and meta-analysis of contemporary prospective studies

Laurent Bertoletti

Poster

Abstract

Balloon Pulmonary Angioplasty in Sickle Cell Disease with Chronic Thromboembolic Pulmonary Hypertension

Mitja Jevnikar

Poster

Abstract

Chronic Thromboembolic Pulmonary Hypertension Associated with Venous Thoracic Outlet Syndrome

Mitja Jevnikar

Poster

Abstract

Assessing pulmonary endarterectomy response in CTEPH with CTPA imaging biomarkers

Xiaohui Ma

Poster

Abstract

The role of medical therapy before and after balloon pulmonary angioplasty: CTEPH AC registry across Japan

Yu Taniguchi

Poster

Abstract

Cardiac phenotyping in response to PEA vs BPA

Tamara Rodenburg

Poster

Abstract

Balloon pulmonary angioplasty complications and pulmonary hemodynamic thresholds.

Barbara Teixeira

Poster

Abstract

The frequency of thyroid disease and treatment in chronic thromboembolic pulmonary hypertension and their effect on outcomes

Derya Kocakaya

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}